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Parkinson’s disease (PD), a progressive neurodegenerative disorder, is characterized by
irreversible dopaminergic neuron loss and intra-neuronal α-synuclein aggregation. High
mobility group box 1 (HMGB1) has been proven to be involved in autophagy dysfunction
induced by α-synuclein accumulation, and the Beclin1-vacuolar protein sorting 34
(Vps34) complex is of great importance to the initiation of autophagy. Nevertheless, the
concrete interaction mechanism between HMGB1, α-synuclein and autophagy remains
elusive, especially in the context of PD. Here in this study, we investigated the interaction
between HMGB1 and α-synuclein in rotenone-induced PD cell models and their roles
in autophagy flux. Results revealed elevated expression and cytosolic translocation of
endogenous HMGB1 upon rotenone exposure. Besides, HMGB1 was found to be able
to co-localize and interact with α-synuclein. Moreover, it had also been proven that
HMGB1 could aggravate α-synuclein aggregation induced autophagy dysfunction via
perturbing Beclin1-Vps34 complex formation. Based on these findings, we propose that
HMGB1 is involved in rotenone-induced dopaminergic cell death via interacting with
α-synuclein, perturbing the autophagy process, aggravating protein aggregation and
finally propelling dopaminergic neurons to move from morbidity to mortality.
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective
degeneration of nigro-striatal dopaminergic system and the Lewy body (LB) formation in remnant
dopaminergic neurons. The existing evidences suggest that aging, gene and environmental toxins
may collectively contribute to the pathogenesis and progression of PD (Dawson and Dawson, 2003;
Di Monte, 2003; Warner and Schapira, 2003), revealing multiple pathogenic mechanisms such as
autophagy dysfunction (Pan et al., 2008), oxidative stress (Jenner, 2003), neuroinflammation (Phani
et al., 2012), etc. Currently, the research focus of PD is mainly centered on the aberrant aggregation
and propagation of pathogenic protein, especially in relation to α-synuclein, a major component
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of LBs. Moreover, blockade of the LBs formation and
dissemination have been proven to be able to partly alleviate
or even reverse the pathogenesis and progression of PD
(Mueller et al., 2005; Müller et al., 2013; Kalia and Kalia,
2015). In particular, autophagy, an important cellular protein
and organelle degradation pathway, plays an important role
in blocking α-synuclein aggregation and dissemination (Xiong
et al., 2012; Xilouri et al., 2016). Hence, it can be presumed that
autophagy dysfunction could lead to intra-neuronal aggregation
and extracellular propagation of α-synuclein, thus debilitating
the dopaminergic neurons and aggravating the Parkinsonian
symptoms.
High-mobility group box 1 (HMGB1), an evolutionarily
conserved DNA-binding protein, has been demonstrated to
be involved in several cellular processes including autophagy,
apoptosis, necrosis and inflammation (Gauley and Pisetsky, 2009;
Gao et al., 2011; Kang et al., 2011; Weber et al., 2015; Yu et al.,
2015). Recently published reports demonstrate that cytosolic
translocated HMGB1 could serve as an important cellular signal
to regulate cellular metabolism and may associate with many
diseases, such as cancer, ischemic stroke, neuropathic pain and
even neurodegenerative diseases (Klune et al., 2008; Sims et al.,
2010; Fang et al., 2012; Kang et al., 2014). In the context of
PD, HMGB1 is not only found to co-localize with α-synuclein
filaments in brain autopsy (Lindersson et al., 2004) but also
found elevated in cerebrospinal fluid and serum (Santoro et al.,
2016). Additionally, systemic administration of neutralizing
antibodies to HMGB1 has also been proven to inhibit the
microglial activation, suppress secondary neuroinflammation
and thus prevent the dopaminergic cell death upon neurotoxin
exposure in PD models (Santoro et al., 2016; Sasaki et al.,
2016). In conclusion, the evidences above collectively indicate
that HMGB1 may serve as a pivotal role in the pathogenesis
of PD.
Beclin1 (Atg6) is an evolutionarily conserved protein family
that has been shown to function in autophagy process in a
wide variety of species (Furuya et al., 2005). In mammalian
cells, Beclin1 function as a vacuolar protein sorting (Vps)
protein and can bind to Class III PI3K Kinase (Vps34), thus
forming a Beclin1-Vps34 complex which is of critical significance
in autophagy modulation (Funderburk et al., 2010). What is
interesting is that Beclin1 was originally identified not as an
autophagy protein but rather as an interaction partner for
B-cell lymphoma 2 (Bcl-2), an anti-apoptotic protein (Liang
et al., 1998). Coincidentally, HMGB1, a novel endogenous
Beclin1 binding protein, was proven to compete with Bcl-2
to orient Beclin1 to autophagosome, thus participating in the
modulation of autophagosome formation (Kang et al., 2010).
Therefore, given the study findings above, it can be presumed
that HMGB1 and Beclin1-Vps34 complex may probably play
an important role in autophagy modulation in the context
of PD.
Here in this study, we primarily detected HMGB1 and
α-synuclein expression upon rotenone exposure, discovering
that HMGB1 could translocate into cytosol to co-localize with
α-synuclein. To further explore whether HMGB1 can interact
with α-synuclein, GFP-HMGB1 and HMGB1-small interfering
RNA (siRNA) are transiently expressed in SH-SY5Y cells with or
without rotenone exposure. Moreover, the interaction between
HMGB1 and Beclin1-Vps34 complex is investigated as well in the
case of HMGB1 overexpression and suppression, respectively.
MATERIALS AND METHODS
Cell Culture
Human neuroblastoma cells (SH-SY5Y) were purchased from
Type Culture Collection of Chinese Academy of Sciences.
SH-SY5Y cells were cultured in DMEM-F12 medium (HyClone,
USA) supplemented with 10% heat-inactivated new-born calf
serum (Gibco, USA) in a humidified incubator with 5% CO2 and
95% fresh air.
Western Blot
Total proteins were extracted from the cell lysates using RIPA
lysis buffer (Cell Signaling Technology, #9806) supplemented
with protease and phosphatase inhibitors (Cell Signaling
Technology, #5872). Protein concentrations of the extracts
were measured with BCA assay kit (Cell Signaling Technology,
#7780). Afterwards, supernatant was boiled with 5× SDS
loading buffer (Boster, China) for 10 min and provisionally
stored at −80◦C. Approximately 60 µg proteins were loaded
onto SDS-PAGE, then electrophoretically transferred to PVDF
(PerkinElmer, USA) membrane and blocked with 5% milk
dissolved in Tris-buffered saline containing 0.1% Tween 20
(TBST) for 1 h at room temperature. The membranes were then
blocked with 5% defatted milk at room temperature for 1 h and
probed overnight at 4◦C with the following primary antibodies:
anti-HMGB1 antibody (ab79823; Abcam, Cambridge, MA, USA;
1:1000 dilution); anti-α-synuclein antibody (ab51253; Abcam,
Cambridge, MA, USA; 1:500 dilution); anti-Beclin1 antibody
(ab51031; Abcam, Cambridge, MA, USA; 1:1000 dilution) and
anti-p62 antibody (Cell Signaling technology, NO.8025S;
1:1000 dilution); anti-LC3A/B antibody (Cell Signaling
technology, NO.12741S; 1:1000 dilution); and anti-β-actin
(ACTB) antibody (CW0281A; Comwin Biotech, USA;
1:3000 dilution). After incubation with horseradish peroxidase-
conjugated secondary antibodies for 1 h at room temperature,
the signals were detected by Kodak Professional Film Developer.
Relative band intensities were quantified using Quantity One
software.
Co-Immunoprecipitation Analysis
SH-SY5Y cells were lysed at 4◦C in ice-cold immunoprecipitation
(IP) assay lysis buffer (Beyotime, China; P0013J) for 10 min,
then the cells lysates were centrifuged for 3 min at 12,000 g.
Concentrations of proteins in the supernatant were determined
by bicinchoninic acid assay (Abcam, UK; ab207003). Then the
extracted proteins were divided into two parts, one contained
whole cell lysis (WCL) which would be assessed by Western blot
(WB) directly and another prepared for co-immunoprecipitation
(Co-IP). Besides, a negative control group was established,
which contained normal cell lysates and would be incubated
by IgG in Co-IP. Before Co-IP, the samples containing equal
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amounts of proteins were pre-cleared with protein A or protein G
agarose/sepharose (Cell Signaling Technology, #9863) at 4◦C for
3 h and subsequently incubated with irrelevant IgG or antibodies
(2–5 µg/ml) in the presence of protein A or G agarose/sepharose
beads (Cell Signaling Technology, #9863) for 2 h at room
temperature or overnight at 4◦C with gentle shaking. After
incubation, agarose/sepharose beads were extensively washed
with PBS, and proteins were eluted by boiling in 2× SDS sample
buffer before SDS-PAGE electrophoresis.
Gene Transfection
Plasmid encoding HMGB1 fused with GFP was provided by
Dr. George Hoppe at University of Pittsburgh and Dr. Marco
Bianchi at San Raffaele University. Control DNA poly β
siRNA and siRNA were purchased from Guangzhou RiboBio
Co. Ltd, China, and were operated according to standard
transfection protocols for cell cultures. GFP-HMGB1 or siRNA-
HMGB1 was transfected into SH-SY5Y cells using Lipofectamine
2000 reagent (Invitrogen, Waltham, MA, USA) according
to the manufacturer’s instructions. In accordance with the
experimental protocols, the cells were prepared for subsequent
treatments 48 h after the transfection procedures.
Immunofluorescence
SH-SY5Y cells were seeded on 12-well plates and fixed in 4%
paraformaldehyde for 10 min before detergent extraction with
0.1% Triton X-100 for 15 min at room temperature. The wells
were saturated with 1% bovine serum albumin in phosphate-
buffered saline (PBS) for 1 h at room temperature and processed
for immunofluorescence with anti-HMGB1 antibodies followed
by Fluorescein Isothiocyanate (FITC)-conjugated anti-rabbit
IgG. Nuclear morphology was analyzed after staining with
the fluorescent dye Hoechst 33342 (Sigma-Aldrich, USA) for
10 min. Cells were washed with PBS three times for 5 min each
between incubation steps. Images were taken under a confocal
microscope.
Transmission Electron Microscopy
Prepared cell samples were quickly rinsed in PBS 3× and fixed
with a 0.1 mol/L phosphate buffer solution (pH 7.4) containing
3% glutaraldehyde plus 2% paraformaldehyde. Next, the cell
samples were fixed by 1% OsO4 for 1 h to produce osmium black
before dehydration. Sections of the cells were prepared with a
diamond knife on a Reichert-Jung Ultracut-E ultra-microtome.
Then the cell samples were stained with UrAc (20 min) followed
by 0.2% lead citrate (2.5 min) for observation under a JEM
1011CX electron microscope (JEOL USA, Inc.). Digital images
were acquired by the Advanced Microscopy Techniques imaging
system.
Cell Morphology and Cell Apoptosis
Evaluation
SH-SY5Y cells were cultured in 6-well plates and treated with
the indicated drug combination for 24 h after transfecting
with/without HMGB1 plasmid or siRNA. The cell morphology
was observed under an inverted microscope (IX70, Olympus,
Japan) and recorded using a CMOS camera (Infinity Lite,
USA). For Hoechst staining, cells cultured on coverslips
in 12-well plates were fixed in 4% paraformaldehyde for
30 min after predesigned treatments. Hoechst 33258 (Sigma,
USA) was used to stain the cell nuclei after PBS washing
for 3× and incubated for 10 min before observing. The
positively stained cells with nuclear deformities were counted
in 10 random fields under the confocal microscope. For
flow cytometry analysis, cells were washed three times with
PBS after harvest and stained with Annexin V-FITC and
propidium iodide (PI) according to the manufacturer’s
instructions. The cells were then washed and analyzed with
a FACScan flow cytometry (Becton Dickinson, Franklin Lakes,
NJ, USA).
Statistical Analysis
All statistical analyses were performed using SPSS 20.0 (SPSS,
Chicago, IL, USA). Data are expressed as mean ± standard
error (SEM). Differences among groups were analyzed by
one-way analysis of variance (ANOVA) followed by Least square
difference’s post hoc test. P < 0.05 was considered significantly
different. All the data were obtained from three independent
experiments.
RESULTS
Elevated HMGB1 and α-Synuclein
Expression Upon Rotenone Exposure
Real-time PCR and WB were used to investigate the expression
level of HMGB1 and α-synuclein upon rotenone exposure.
Results showed that the HMGB1 expression (both at
mRNA and protein level) was elevated in a concentration
dependent manner. Moreover, HMGB1 protein expression
pattern detected by WB was consistent with that of
HMGB1 mRNA (Figures 1A,C). While in the time course
of HMGB1 mRNA expression, with persistent 1 uM rotenone
incubation, it revealed a constant increase which peaked at
24 h and then slightly decreased at 48 h (Figure 1B). In
contrast, α-synuclein expression demonstrated a time and
concentration dependent manner under rotenone treatment
(Figures 1C,D).
HMGB1 Presented Cytosolic Translocation
and Interaction With α-Synuclein Upon
Rotenone Exposure
The interaction between HMGB1 and α-synuclein was primarily
investigated by laser confocal microscopy and then confirmed by
Co-IP. The laser confocal microscopy indicated that HMGB1was
mainly located in the nucleus and scarcely existed in the
cytoplasm in control SH-SY5Y cells (Figure 2A). Nevertheless,
after 1 uM rotenone incubation for 24 h, HMGB1 expression
levels were markedly elevated, with some shuttling from
the nucleus to the cytoplasm (Figure 2A). Besides, the
HMGB1 distribution pattern has changed as well, transforming
from a granularly concentrated pattern to a muddily dispersive
one (Figure 2A). Moreover, when compared with control
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FIGURE 1 | High mobility group box 1 (HMGB1) and α-synuclein overexpressed upon rotenone exposure. SH-SY5Y cells were treated either with rotenone
concentration increment (0, 0.4 µM, 0.8 µM, 1 µM, 2 µM) pattern (A) or with time stretch pattern (0 h, 12 h, 24 h or 48 h) exposed to 1 µM rotenone abidingly
(B). The mRNA levels of HMGB1 were measured by RT-PCR in (A,B), while the protein expression level of HMGB1 and α-synuclein were determined by Western blot
(WB; C,D). Relative intensity is normalized to that of β-actin (ACTB; C,D). Data are presented as the mean ± standard error (SEM) from three independent
experiments. ∗P < 0.05.
FIGURE 2 | HMGB1 translocated to cytoplasm and interacted with α-synuclein. The overall HMGB1 expression increased under rotenone treatment (1 µM,
24 h), accompanying cytoplasmic translocation (marked by arrows) as proven by confocal microscopy (A). The interaction between HMGB1 and α-synuclein were
further confirmed by co-immunoprecipitation (Co-IP), which indicated that HMGB1 and α-synuclein could form co-precipitation complex upon rotenone exposure
(B). WCL, whole cell lysate; Rot, rotenone; Ctrl, control; IP, immunoprecipitation; WB, Western blot.
group, HMGB1 and α-synuclein had been confirmed to form
co-precipitation complex after rotenone exposure as proven
by Co-IP (Figure 2B). In conclusion, the outcomes above
indicated that HMGB1 could present overexpression, cytosolic
translocation and interaction with α-synuclein upon rotenone
exposure.
HMGB1 Regulated α-Synuclein Expression
To further explore the relationship between HMGB1 and
α-synuclein, wild-type HMGB1-GFP fusion protein and
HMGB1-siRNA were transiently expressed in SH-SY5Y cells
with or without rotenone exposure (Figure 3A). What is
interesting is that HMGB1 expression level, compared with
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FIGURE 3 | HMGB1 regulated α-synuclein expression. SHSY-5Y cells were transfected with GFP-HMGB1 plasmid and small interfering RNA
(siRNA)-HMGB1 respectively. Confocal microscopy was used to detect HMGB1 expression and subcellular location after rotenone treatment (1 µM, 24 h)
(A). The expression level of HMGB1 and α-synuclein were determined by WB after GFP-HMGB1 plasmids (B) or siRNA-HMGB1 (C) transfection. Relative intensity
is normalized to that of ACTB/β-actin (B,C). Data are presented as the mean ± SEM from three independent experiments. ∗#P < 0.05.
respective control group, were significantly elevated upon
rotenone exposure, no matter the upward or downward
manipulation of HMGB1. Moreover, the HMGB1 distribution
patterns demonstrated similar changes to that identified
in Figure 2A under rotenone treatment, regardless of the
HMGB1 manipulation approaches (Figure 3A). The expression
level of HMGB1 had also been proven to coincide with that
of α-synuclein both in the context of HMGB1 manipulation
and rotenone exposure. In particular, HMGB1 overexpression
could increase α-synuclein expression and the positive effect
could be further intensified by rotenone incubation (Figure 3B).
While in the context of HMGB1 suppression, it was found that
α-synuclein expression decreased as well, but partly restored
by rotenone exposure (Figure 3C). Therefore, the study results
above indicated that HMGB1 might regulate the expression of
α-synuclein, while rotenone exposure could exert a positively
intensifying effect.
HMGB1 Mediated Autophagy Impairment
via Perturbing Beclin1-Vps34 Complex
Formation
Given that HMGB1 could modulate α-synuclein expression
and abnormal α-synuclein aggregates were usually degraded
by autophagy-lysosome pathway, whether HMGB1 could
exert a modulatory effect on autophagy was thereby
investigated. In comparison with control group (Figure 4A),
after incubating SH-SY5Y cells with 1 µM rotenone
for 24 h, it revealed autophagosome formation and
mitochondrial deformation under transmission electron
microscope (Figure 4B), which could be further aggravated
by HMGB1 overexpression (Figure 4C). Nevertheless,
the mitochondrial deformation in SH-SY5Y cells could
be partly alleviated when transfected with siRNA-
HMGB1, but still accompanying sporadic autophagosomes
(Figure 4D).
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FIGURE 4 | The ultrastructural view of HMGB1 mediated autophagy dysfunction. In control group, SH-SY5Y cells presented normal cellular ultrastructure
and mitochondria (A, marked by triangles). In comparison, autophagosomes (marked by arrows) could be observed in Rot group (incubation with rotenone for 24 h),
accompanying deformed mitochondria and swelling mitochondrial cristae (B, marked by triangles). When transfected with siRNA-HMGB1, the mitochondrial
deformation in Rot + siRNA-HMGB1 group (incubation with rotenone for 24 h after siRNA-HMGB1 transfection) was partly alleviated (C, marked by triangles), but still
presenting sporadic autophagosomes (marked by arrows). By contrast, the GFP-HMGB1 group (incubation with rotenone for 24 h after GFP-HMGB1 transfection)
revealed severely deformed cellular ultrastructure and numerous autophagosomes (D, marked by arrows).
FIGURE 5 | HMGB1 mediated cellular autophagy dysfunction via Beclin1-vacuolar protein sorting 34 (Vps34) complex perturbation. SH-SY5Y cells
were incubated with 1 uM rotenone for 24 h after GFP-HMGB1 plasmids (A) or siRNA-HMGB1 (B) transfection. The expression of light chain 3 (LC3) and P62 in
different groups was determined by WB (A,B). HMGB1, in the context of overexpression or rotenone treatment, could interact with Beclin1 and thereby inhibited the
Beclin1-Vps34 complex formation, while HMGB1 suppression could partly reverse the autophagy dysfunction (C). ∗#P < 0.05.
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FIGURE 6 | HMGB1 influenced cellular morphology and viability. Cellular morphology was observed under a phase-contrast microscope (×200 magnifications)
when treated with 1 µM rotenone after transfection with GFP-HMGB1 plasmids or siRNA-HMGB1 (A). SH-SY5Y cells were stained with Hoechst 33258 to observe
the nuclear structure alterations (B, marked by arrows). The cellular viability and apoptosis rate were determined by Hoechst 33258 staining (C) and flow cytometry
(D) in different groups, indicating that GFP-HMGB1 transfection could exacerbate rotenone induced cell death while HMGB1 suppression could partly alleviate it.
∗P < 0.05 compared with control group; #P < 0.05 compared with the other groups.
To confirm the effect of HMGB1 on autophagy, we explored
the expression changes of autophagy associated proteins
including microtubule-associated protein light chain 3-II
(LC3-II) and p62 upon HMGB1 manipulation (Figures 5A,B).
As a result, we found that HMGB1 overexpression could
remarkably augment autophagymarker protein (LC3-II and p62)
expression no matter with or without rotenone pretreatment
(Figure 5A). In contrast, inhibition of HMGB1 expression
by siRNA could obviously reduce LC3-II and p62 expression,
but partly restored by rotenone incubation (1 µM, 24 h;
Figure 5B). In general, the expression level of LC-I, LC-II and
p62 signified the feasibility of autophagy flux. When revealing
more conversion of LC-I to LC-II and less p62 expression,
it indicated feasibility of the autophagy flux; while the more
conversion of LC-I to LC-II and elevated p62 expression
implied normal initiation but not sustaining of autophagy
flux. In conclusion, the study outcomes above indicated that
HMGB1 could initiate but not sustain the autophagy flux.
To further clarify how HMGB1 modulated the autophagy
flux and whether Beclin1 or Vps34 was involved in this
process, we transiently transfected SH-SY5Y cells with
GFP-HMGB1 or siRNA-HMGB1 and performed Co-IP to
explore potential interaction. As a result, it revealed that
endogenous Beclin1 normally bind to Vps34 but not HMGB1,
as shown by Co-IP in control group (Figure 5C). However, after
rotenone treatment, Beclin1 turned to bind to HMGB1 to form
HMGB1-Beclin1 complex. Considering that HMGB1 expression
could be upregulated upon rotenone treatment (Figures 1–3), it
could be presumed that HMGB1 could disintegrate the Beclin1-
Vps34 complex (Figure 5C). Moreover, HMGB1 overexpression
maintained the HMGB1-Beclin1 interaction no matter rotenone
was added or not. In contrast, when cells were transfected
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with siRNA to reduce HMGB1 expression, the interaction
between Vps34 and Beclin1 in cytoplasm would restore
(Figure 5C). Hence, these results suggested that HMGB1 had
a higher affinity for Beclin1 and thereby suppress autophagy
process by blocking the Beclin1-Vps34 complex formation,
all of which could be positively intensified by rotenone
exposure.
HMGB1 Influenced Cellular Morphology
and Viability
Morphological changes in SH-SY5Y cells were assessed
by phase-contrast microscope, which indicated that
HMGB1 overexpression or rotenone exposure could contribute
to cellular shrinkage and nuclear structure destruction
(Figures 6A,B). Hoechst 33258 staining demonstrated
nuclear fragmentation, karyopyknosis, karyolysis and
chromatin margination (Figure 6B, marked by arrows),
which could be used to indirectly indicate cell viability
(Figure 6C). Moreover, GFP-HMGB1 plasmids transfection
further aggravated the cellular morphology and nuclear
structure damages. Nevertheless, HMGB1 suppression
could partly alleviate these phenomena (Figures 6A–C).
The cell apoptosis rate was determined by flow cytometry.
Data showed that rotenone treatment could induce an
apoptosis rate of 12.00 ± 0.23% and HMGB1 overexpression
resulted in a higher apoptosis rate of 29.24 ± 0.21%,
while HMGB1 suppression pre-treatment (siRNA-
HMGB1 transfection) only result in an apoptosis rate of
7.95± 0.14% (Figure 6D).
DISCUSSION
HMGB1, a non-histone DNA binding protein, is capable
of promoting DNA restoration, enhancing transcription in
the nucleus and regulating cell differentiation, inflammation,
apoptosis, autophagy and cell cycle in the cytoplasm (Livesey
et al., 2012; Yang et al., 2013). Besides, HMGB1 is proven
to be involved in several neurodegenerative disorders, such as
amyotrophic lateral sclerosis (ALS; Lo Coco et al., 2007; Hwang
et al., 2013), Alzheimer’s disease (AD; Takata et al., 2003, 2012;
Jang et al., 2013), Huntington’s disease (Okazawa, 2011; Min
et al., 2013) and PD (Lindersson et al., 2004; Song et al., 2014;
Santoro et al., 2016; Sasaki et al., 2016). For example, HMGB1was
demonstrated to promote disease progression by aggravating
neuroinflammation and selectively damaging motor neurons in
a mouse model of ALS (Lo Coco et al., 2007). In addition, a more
recent study showed that systemic administration of neutralizing
antibodies to HMGB1 could relieve dopaminergic neuron death
upon neurotoxin exposure via inhibition of microglial activation
FIGURE 7 | Diagram illustrating the mechanisms implied in HMGB1 mediated autophagy impairment. HMGB1 can bind to Beclin1 upon rotenone
exposure or manipulative overexpression and thereby perturbs the Beclin1-Vps34 complex formation, which subsequently results in α-synuclein accumulation. While
the accumulated α-synuclein can inhibit the cytosolic translocation and facilitate the disassociation of Beclin1-Vps34 complex, thus forming a vicious cycle to drive
the dopaminergic neurons from morbidity to mortality in PD.
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and subsequent neuroinflammation in PD models (Santoro
et al., 2016; Sasaki et al., 2016), thus implying the involvement
of HMGB1-modulated neuroinflammation dysregulation in the
pathogenesis of PD. While in the context of AD, HMGB1 was
proven to be involved in the accumulation of amyloid-β-
containing neuritic plaques which was, as a matter of fact,
caused by impaired autophagy process (Takata et al., 2003).
Also, it had also been demonstrated that HMGB1 could serve
as a ligand for α-synuclein, binding preferentially to α-synuclein
aggregates or presenting in LBs just as identified in brain tissue
of dementia with LBs or PD patients (Lindersson et al., 2004).
Moreover, Song et al revealed that overexpressed α-synuclein
could bind to HMGB1, impair its cytosolic translocation and
block the HMGB1-Beclin1 interaction, ultimately resulting in
autophagy inhibition (Song et al., 2014). However, whether
and how HMGB1 exert a modulatory effect on autophagy
still remain elusive. Herein, we intend to investigate the
exact interaction mechanism between HMGB1, autophagy and
α-synuclein, aiming to push the autophagy research in PD a step
further.
As we all know, cellular autophagy may lead to two opposite
outcomes: closely modulated autophagy can remove long-lived
proteins and dysfunctional organelles and thus exert protective
effects (Kang et al., 2010; Ebrahimi-Fakhari et al., 2012),
while disorganized autophagy has been confirmed to induce
autophagic cell death and even autosis (Liu and Levine, 2015).
Therefore, it can be presumed that autophagy is a double-
edged sword (Shintani and Klionsky, 2004; Tung et al., 2012), of
which Beclin1 is, in fact, a vital factor to balance the autophagy-
induced cytoprotective and cytotoxic effects (Erlich et al., 2006).
While a study in PC12 cells revealed that intracellular promotion
of either HMGB1 or Beclin1 could up-regulate α-synuclein
degradation and ameliorate α-synuclein mediated autophagy
inhibition (Wang et al., 2016), but the relationship between
HMGB1 and Beclin1 in autophagy process still remained elusive.
Moreover, the downstream effector molecules of HMGB1 and
Beclin1 are unknown as well. To clear up the doubts above, we
launched an in-depth investigation.
In our study, we found that HMGB1 and α-synuclein
expression could be markedly elevated in a concentration or
time dependent manner upon rotenone exposure, and the
overexpressed HMGB1 could also translocate into cytosol
and interact with α-synuclein. Moreover, HMGB1 could
increase α-synuclein expression and the positive effect could
be further intensified by rotenone incubation. Beyond that,
HMGB1 overexpression had also been proven to promote the
initiation but not sustaining of autophagy, as a result of more
conversion of LC3-I to LC3-II and elevated p62 expression. As
a result, the block of autophagy flux lead to further α-synuclein
overexpression and subsequent aggregation (Mader et al.,
2012; Garcia-Garcia et al., 2013), thus forming a vicious
cycle to propel the condition from bad to worse. Similarly,
a study had revealed the manipulatively overexpressed
α-synuclein could bind to both cytosolic and nuclear
HMGB1, impair its cytosolic translocation and subsequent
interaction with Beclin1, which finally resulted in autophagy
inhibition and further aggravated α-synuclein accumulation
(Figure 7; Song et al., 2014). Nevertheless, overexpression
of Beclin1 could instead restore autophagy, promote α-
synuclein clearance (Song et al., 2014) and ultimately break the
vicious cycle shown in Figure 7. Moreover, HMGB1 inhibitor
glycyrrhizin pretreatment or HMGB1 knockdown had also
been proven to facilitate the autophagy flux and rescue
3-nitropropionic acid induced striatal damage (Qi et al.,
2015), which is precisely consistent with the study results.
In conclusion, this study has identified that HMGB1 have a
higher affinity for Beclin1 and thereby perturb the Beclin1-
Vps34 complex formation, thus resulting in subsequent
autophagy dysfunction and α-synuclein accumulation.
Based on the study results and pre-existing conclusions, it
can be further presumed that the dysfunctional autophagy
induced α-synuclein accumulation can in turn exacerbate
HMGB1 mediated autophagy failure to form a vicious cycle
(Figure 7).
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